Adiponectin has been associated with low diabetes risk. The metabolic effects of adiponectin are mediated by adiponectin receptors 1 (ADIPOR1) and 2 (ADIPOR2). We conducted a prospective, nested case-control study of 714 cases of type 2 diabetes and 1,120 control subjects. Six polymorphisms in ADIPOR1 and 16 polymorphisms in ADI-POR2 were determined. Haplotypes inferred from ADI-POR1 polymorphisms were significantly associated with diabetes risk (overall test, ؊2log-likelihood ؍ 15.1 on 5 df; P ؍ 0.0098). A single copy of haplotype 001100 (0, common allele; and 1, minor allele) was associated with 24% M any studies have documented that adiponectin, which is a hormonal cytokine secreted exclusively by adipose tissue, has strong insulin-sensitizing, anti-inflammatory, and antidiabetes effects (1,2). Adiponectin improves insulin sensitivity by affecting the metabolism of glucose and lipids in skeletal muscle and liver (3). In earlier analyses, we have found that blood adiponectin levels and variations in the adiponectin gene (ADIPOQ, also known as APM1) were associated with type 2 diabetes and cardiovascular risk (4 -6).Recent evidence indicates that the metabolic regulation of adiponectin is mainly mediated by two types of receptors, adiponectin receptors 1 (ADIPOR1) and 2 (ADI-POR2) (7,8). Downregulation of ADIPORs may blunt adiponectin-induced signaling (7). The expression of adiponectin receptor has been related to in vivo parameters of glucose and lipid metabolism (9) and was found to be lower in diabetic patients (10). The polymorphisms in the ADIPOR1 gene were recently associated with adiposity, insulin resistance, and high liver fat (11-13). A few studies have investigated the associations between the variations in ADIPOR1 and ADIPOR2 genes and the risk of type 2 diabetes but generated mixed results (14 -17). These studies, however, were largely limited by small sample size or a cross-sectional nature in design. The relation between ADIPOR genetic variability and diabetes risk has yet to be evaluated in prospective settings.In this study, we comprehensively examined the variations in ADIPOR1 and ADIPOR2 genes and the risk of type 2 diabetes in a nested, case-control study from the Nurses' Health Study cohort. We selected linkage disequilibrium (LD) tagging single nucleotide polymorphisms (SNPs) that capture the maximum variance in both genes and also included polymorphisms that were previously associated with diabetes risk.
RESEARCH DESIGN AND METHODSThe Nurses' Health Study was established in 1976 when 121,700 female registered nurses aged 30 -55 years and residing in 11 large U.S. states completed a mailed questionnaire on medical history and lifestyle (18). The lifestyle factors, including smoking, menopausal status and postmenopausal hormone therapy, and body weight, have been updated by validated questionnaires every 2 years. Samples for the present case-control study were selected from a subcohort of 32,826 women who provided a blood sample between 1989 and 1990 and were free from diabetes, cardio...